Emily Bryer Tomasulo, DO
Assistant Professor of Clinical Medicine (Hematology-Oncology)
Attending Physician , Hospital of the University of Pennsylvania
Attending Physician , Pennsylvania Hospital
Program Lead, Cellular and Transplant Program, Pennsylvania Hospital, Pennsylvania Hospital
Department: Medicine
Contact information
230 W Washington Square
Philadelphia, PA 19106
Philadelphia, PA 19106
Education:
BS (Spanish Major, Minors in Psychology and Biology, Honors in Neuroscience)
Schreyer Honors College of The Pennsylvania State University, 2013.
DO (Medicine )
Philadelphia College of Osteopathic Medicine, 2017.
Permanent linkBS (Spanish Major, Minors in Psychology and Biology, Honors in Neuroscience)
Schreyer Honors College of The Pennsylvania State University, 2013.
DO (Medicine )
Philadelphia College of Osteopathic Medicine, 2017.
Selected Publications
Emily Tomasulo, Andy Itsara, Mark Haigney, Douglas R. Rosing, Inhye E. Ahn, Cody Peer, Beth A. Kozel, Teresa Luperchio, Grace Ge, William D. Figg, Adrian Wiestner, and Clare Sun: Sudden Death and Asymptomatic Arrhythmia in CLL Patients Treated with Ibrutinib. Heart Rhythm October 2025 Notes: https://doi.org/10.1016/j.hrthm.2025.10.014.Christopher Pleyer, Emily Tomasulo, et. al: Activity and Safety of Venetoclax without Anti-CD20 Lead-in Therapy in Treatment Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia. Blood Supplement, American Society of Hematology Annual Meeting, San Diego, CA. Dec 2024 Notes: "Poster Presentation"
Emily B. Tomasulo, Dylan Therwhanger, Emeline R. Chong, Mitchell E. Hughes, Michael Fradley, and Stephen J. Schuster: Resolution of ibrutinib-associated hypertension with transition to alternate covalent BTKi Blood Supplement, American Society of Hematology Annual Meeting, San Diego, CA. Dec 2024 Notes: "Poster Presentation"
Emily Tomasulo, Shira Paul, Rui Mu, Xin Tian, Jonathan Chen, Christopher Pleyer, Adrian Wiestner, Clare Sun: Interruption of BTK inhibitor improves response to SARS-CoV-2 booster vaccination in patients with CLL. Leukemia & Lymphoma 64(14): 2306-2315. Dec 2023.
Itsara A, Sun C, Bryer E, et al. : Long-Term Outcomes in Chronic Lymphocytic Leukemia Treated with Ibrutinib: 10-Year Follow-up of a Phase 2 Study. Blood Supplement, American Society of Hematology, Washington, DC Dec 2023 Notes: "Poster Presentation"
Emily Tomasulo: Chronic Lymphocytic Leukemia Chapter Bethesda Handbook of Hematology 2023.
Bryer E, Itsara A, Ahn I et al.: Ibrutinib-associated sudden death in patients with CLL. Blood, American Society of Hematology, Orlando, FL. 140(Supplement 1), Dec 2022 Notes: "Poster Presentation"
Bryer EJ, Destefano C, Kazandjian D.: Current and prospective antibody-based therapies in multiple myeloma Semin Oncol 49(1): 41-47, Feb 2022.
Bryer EJ, Stein E, Goldberg S.: Multivessel Coronary Artery Disease. Mayo Clinic Proceedings: Innovations, Quality, and Outcomes. Dec 2020 Notes: https://mcpiqojournal.org/action/showPdf?pii=S2542-4548%2820%2930150-8.
Bryer E, Dew A, Hill E, et al.: A phase II pilot study of avelumab in combination with hypofractionated radiotherapy in patients with relapsed refractory multiple myeloma. Blood 136(Supplement 1), Nov 2020 Notes: https://ashpublications.org/blood/article/136/Supplement%201/10/473693/A-Phase-II-Pilot-Study-of-Avelumab-in-Combination.